news

Winter chores. Save the skin

Winter, as a rule, brings with it not only the New Year holidays, annual reports and another batch of promises to start a new life from January 1st. With it comes frost, cold wind and constant temperature changes – all that sometimes spoils our mood and makes our skin cry for help.   And no wonder: …

Winter chores. Save the skin Read More »

The secret of every third

There are things that are not easy to discuss with others – even if it is a beloved husband or girlfriend. We women easily talk to each other about men, children, shopping and relationships. We have learned to open the most hidden corners of our souls, but we are often too shy to share what really worries …

The secret of every third Read More »

Involuntary urination during pregnancy and after childbirth.

The secret of every third According to studies * , 36% of women experience involuntary urination during pregnancy and after childbirth. But these nine months are one of the most beautiful periods in a woman’s life. How to make them more comfortable? What is the reason? During pregnancy and after childbirth, the pelvic floor muscles that support the bladder …

Involuntary urination during pregnancy and after childbirth. Read More »

Sanofi-Aventis may initiate hostile takeover of Genzyme

French pharmaceutical company Sanofi-Aventis SA may initiate a hostile takeover of US biotech company Genzyme Corp. if the management of the latter refuses the acquisition offer, Citgroup Inc. analysts believe. Mark Dainty and Yaron Werber.

FDA Approves Combination Antihypertensive Tribenzor™

On July 26, the Japanese company Daiichi Sankyo Co. Ltd.” announced that the US Food and Drug Administration (FDA) has approved its combination drug Tribenzor™ (olmesartan + amlodipine + hydrochlorothiazide) for the treatment of hypertension in patients whose blood pressure is unresponsive to other combination antihypertensive drugs. means. Daiichi Sankyo notes that Tribenzor simplifies dosing regimens and also …

FDA Approves Combination Antihypertensive Tribenzor™ Read More »

Merck&Co. completed Q2 2010 with a 52% decline in net profit

In the II quarter of 2010, the net profit of the American pharmaceutical company Merck & Co. decreased by 52% due to increased costs, in particular administrative and restructuring, as well as a sharp decrease in profits from partnerships.